UK approves Pfizer-BioNTech’s COVID booster targeting BA.4/5TherapeuticsBritain’s health regulator on Wednesday approved a COVID-19 booster from Pfizer Inc and partner BioNTech SE targeting the Omicron BA.4 and BA.5 sub-variants and the original coronavirus strain. Read more November 9, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/06/ReutersPfizerBioNTech6-24-2022.jpg 805 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-11-09 08:14:162022-11-09 09:25:05UK approves Pfizer-BioNTech’s COVID booster targeting BA.4/5